GGrantIndex
← Leaderboards

Arshad Rahman

University Of Illinois At Chicago

$8,589,196
Attributed
$14,087,490
Total exposure
7
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$14,087,490 · 7

By mechanism

R01$14,087,490 · 7

Top collaborators

Most similar at University Of Illinois At Chicago

Same institution · by research overlap

Others in their field

Top investigators on “Lung Injury

Research focus

Lung InjuryInjuryLungEndothelial CellsInflammatoryMediatingSignal TransductionIn VivoThrombinBaseEndotheliumIn VitroFunctional DisorderBlood VesselsAcute Lung InjuryAdult Respiratory Distress SyndromeInflammationMouse ModelNovel Therapeutic InterventionPublic HealthMortalityPathogenesisRespiratory FailureCritical Illness

Grant awards (31)

MAM Proteins in Lung Vascular Injury$694,879
R01 · FY2025 · HL
MAM Proteins in Lung Vascular Injury$680,982
R01 · FY2024 · HL
MAM Proteins in Lung Vascular Injury$694,879
R01 · FY2023 · HL
Mitigating Acute Lung Injury by Cell-specific Targeting of MTOR$589,429
R01 · FY2023 · HL · contact PI
Mitigating Acute Lung Injury by Cell-specific Targeting of MTOR$589,429
R01 · FY2022 · HL · contact PI
Mitigating Acute Lung Injury by Cell-specific Targeting of MTOR$589,429
R01 · FY2021 · HL · contact PI
Regulation of Endothelial-Neutrophil Interaction and Lung Vascular Permeability in Sepsis$426,189
R01 · FY2021 · GM · contact PI
Mitigating Acute Lung Injury by Cell-specific Targeting of MTOR$589,429
R01 · FY2020 · HL · contact PI
Novel Peptide/siRNA Nanoparticles for Treatment of Acute Lung Injury$539,108
R01 · FY2020 · HL
Regulation of Endothelial-Neutrophil Interaction and Lung Vascular Permeability in Sepsis$426,189
R01 · FY2020 · GM · contact PI
Novel Peptide/siRNA Nanoparticles for Treatment of Acute Lung Injury$539,108
R01 · FY2019 · HL
ER-Mitochondrial Control of Acute Lung Injury$479,590
R01 · FY2019 · HL
Regulation of Endothelial-Neutrophil Interaction and Lung Vascular Permeability in Sepsis$426,189
R01 · FY2019 · GM · contact PI
Novel Peptide/siRNA Nanoparticles for Treatment of Acute Lung Injury$539,108
R01 · FY2018 · HL
ER-Mitochondrial Control of Acute Lung Injury$479,590
R01 · FY2018 · HL
Regulation of Endothelial-Neutrophil Interaction and Lung Vascular Permeability in Sepsis$426,189
R01 · FY2018 · GM · contact PI
Novel Peptide/siRNA Nanoparticles for Treatment of Acute Lung Injury$592,411
R01 · FY2017 · HL
ER-Mitochondrial Control of Acute Lung Injury$479,590
R01 · FY2017 · HL
ER-Mitochondrial Control of Acute Lung Injury$478,292
R01 · FY2016 · HL
Regulation of Lung Authopagy and Inflammation$383,750
R01 · FY2016 · HL · contact PI
Regulation of Lung Authopagy and Inflammation$377,993
R01 · FY2015 · HL · contact PI
Regulation of Lung Authopagy and Inflammation$376,075
R01 · FY2014 · HL · contact PI
Regulation of Lung Authopagy and Inflammation$361,255
R01 · FY2013 · HL · contact PI
G-protein-induced Signaling of PMN-mediated Lung Injury$308,000
R01 · FY2010 · HL · contact PI
G-protein-induced Signaling of PMN-mediated Lung Injury$308,000
R01 · FY2009 · HL · contact PI
G-protein-induced Signaling of PMN-mediated Lung Injury$308,000
R01 · FY2008 · HL · contact PI
G-protein-induced Signaling of PMN-mediated Lung Injury$304,760
R01 · FY2007 · HL · contact PI
G-protein-induced Signaling of PMN-mediated Lung Injury$275,625
R01 · FY2005 · HL
G-protein-induced Signaling of PMN-mediated Lung Injury$275,625
R01 · FY2004 · HL
G-protein-induced Signaling of PMN-mediated Lung Injury$275,625
R01 · FY2003 · HL
G-protein-induced Signaling of PMN-mediated Lung Injury$272,773
R01 · FY2002 · HL